Why the study?
Does Patent Ductus Arteriosus stent improve outcomes compared to Modified Blalock-Taussig shunt in infants with ductal-dependent pulmonary blood flow?
Does Patent Ductus Arteriosus stent improve outcomes compared to Modified Blalock-Taussig shunt in infants with ductal-dependent pulmonary blood flow?
PDA stenting is a reasonable alternative to BT shunting in select infants with ductal-dependent pulmonary blood flow, offering similar primary outcomes with potential benefits in morbidity and pulmonary artery growth.
No takes yet. Share an insight, caveat, or question.
PDA stenting may reduce morbidity and improve pulmonary artery growth in select infants; leaves open need for randomized confirmation.
Glatz et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: